New diabetes clinical trial: TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT
Published on: August 23, 2025 at 11:00PM
Conditions: Type 2 Diabetes (T2DM)
Interventions: Drug: Metformin XR 1000mg; Drug: Valsartan 80mg Tablet; Drug: Valsartan 160mg tablet; Drug: Celecoxib (Celebrex®) 100mg; Drug: Celecoxib (Celebrex®) 200mg; Drug: Metformin XR 500 mg
Sponsors: Myopharm Limited
Not yet recruiting
https://ift.tt/cHFSoZv
Conditions: Type 2 Diabetes (T2DM)
Interventions: Drug: Metformin XR 1000mg; Drug: Valsartan 80mg Tablet; Drug: Valsartan 160mg tablet; Drug: Celecoxib (Celebrex®) 100mg; Drug: Celecoxib (Celebrex®) 200mg; Drug: Metformin XR 500 mg
Sponsors: Myopharm Limited
Not yet recruiting
https://ift.tt/cHFSoZv
Comments
Post a Comment